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Abstract 14 
Farrowing is a critical time for sows and piglets. Poor post-farrowing sow recovery, 15 
and piglet mortality represent a welfare concern, as well as an economic loss to the pig 16 
industry. Providing a non-steroidal anti-inflammatory drug (NSAID) to the sow post-17 
farrowing may improve sow welfare and productivity and thereby improve health status and 18 
welfare of the piglets, which would be of economic benefit to pig producers. This study 19 
investigated the production effects of providing the NSAID ketoprofen post-farrowing, to 24 20 
primiparous (gilts) and 32 multiparous (sows) breeding pigs, in a randomised, blinded, 21 
placebo-controlled trial. Gilts and sows were allocated to receive ketoprofen (treated) or the 22 
equivalent volume of saline (control) by intramuscular injection 1.5 hours after the last piglet 23 
birth. Data collected included sow feed intake, immune transfer (colostrum and piglet serum 24 
immunoglobulin-G (IgG)), nursing behaviour and piglet weight, and mortality. An additional 25 
factor in this study was that 13 individuals required additional treatment in the days after 26 
farrowing for post-farrowing illness. Therefore, data were analysed using mixed models, 27 
including treatment (treated or control), parity group (gilt or sow), and additional treatment 28 
(yes or no) as fixed factors. Stepwise binomial logistic regression was used to analyse the 29 
association between the experimental factors (treatment, additional treatment, gilt or sow), 30 
along with other gilt/sow, litter, and piglet-based measures, with piglet death before weaning. 31 
Few treatment effects were seen, with parameters being more affected by whether gilts and 32 
sows were treated for illness, or between gilts and sows. The only variable to differ by 33 
treatment was suckle grunt duration, which was greater for control compared with treated 34 
dams (P = 0.05). Feed consumption was greater for sows compared with gilts on days 6 and 7 35 
post-farrowing, and serum IgG was greater in piglets from sows than gilts (P < 0.05). Feed 36 
consumption was reduced in dams needing additional treatment, from days 2-7 post-37 
farrowing, and those developing illness consumed less feed overall (P = 0.004). The best 38 
  
regression model for predicting the odds of a piglet dying before weaning included number 39 
born alive (P = 0.03), requiring additional treatment (P = 0.006), being male (P = 0.0005), 40 
and pre-farrowing gilt/sow back-fat (P < 0.0001), which increased the log-odds of death, 41 
whereas, piglet body weight decreased the log-odds of death (P < 0.0001). This study did not 42 
demonstrate clear benefits to ketoprofen, however, high individual variation in piglet 43 
mortality, indicates potential for targeted NSAID use.  44 
 45 
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Introduction 47 
 Farrowing is a critical time in pig production. A common feature of modern pig 48 
production is increased litter size, and as the sow must produce enough milk to feed the litter, 49 
feed volume and composition must adjust to cope with the increased demand (Theil, 2015).  50 
Further, each piglet must have access to a functioning teat as soon as possible after birth to 51 
consume colostrum, followed by milk in order to survive (Baxter et al., 2013). Therefore, the 52 
sow must recover quickly following farrowing, including feeding and drinking. However, at 53 
that time the immunocompetence of the sow is impaired and as parturition is physically 54 
demanding, the vulnerability to illness in early lactation is increased (Friendship and 55 
O’Sullivan, 2015).  56 
Post-partum dysgalactia syndrome (PPDS) describes any condition that affects milk 57 
production in the sow, including infections of the uterine tract (metritis) and udder (mastitis), 58 
but milk production can also decline with no obvious signs of infection (Klopfenstein et al., 59 
2006). A number of non-infectious causes of PPDS have been discussed (Klopfenstein et al., 60 
2006) and pain experienced by the sow could contribute to a decreased interest in the piglets 61 
  
and a reduction in milk let down (Peltoniemi and Oliviero, 2015). This has resulted in recent 62 
research administering non-steroidal anti-inflammatory drugs (NSAIDs) post-farrowing and 63 
measuring the benefits to health, welfare and productivity (Homedes et al., 2014; Mainau et 64 
al., 2016, 2012; Sabaté et al., 2012; Tenbergen et al., 2014; Viitasaari et al., 2014, 2013).  65 
A previous study, involving 15 commercial farms, investigated the production 66 
benefits of providing the NSAID ketoprofen post-farrowing to all sows, and demonstrated a 67 
reduction in piglet mortality and a greater number of piglets weaned (Homedes et al., 2014). 68 
Another study found no piglet performance benefits of administering ketoprofen, but did 69 
identify other sow health and welfare benefits including a reduced loss in back-fat, body 70 
condition and constipation, less severe shoulder sores, and a delay in feed refusal (Viitasaari 71 
et al., 2013). Two studies in which meloxicam was administered after farrowing found no 72 
mortality differences but did show an increased average daily weight gain of low birth weight 73 
piglets (Mainau et al., 2012) and a tendency for increased piglet weight gain of litters of 11 to 74 
13 piglets (Tenbergen et al., 2014). Another study using oral meloxicam, demonstrated 75 
improvements in piglet weaning weight, average daily gain, and plasma IgG concentrations 76 
measured on day 1 and 2 post-farrowing (Mainau et al., 2016). The administration of 77 
NSAIDs in addition to antibiotics has also been shown to aid in treatment of infectious causes 78 
of PPDS (e.g. Hirsch et al., 2003; Tummaruk and Sang-Gassanee, 2013) and on a farm with a 79 
high incidence of PPDS, piglet mortality was reduced and the number of piglets weaned 80 
increased in sows given ketoprofen and antibiotics (Sabaté et al., 2012).   81 
Ketoprofen is an NSAID with anti-inflammatory, analgesic, and antipyretic 82 
properties, which was shown to reach maximum levels approximately one hour after 83 
intramuscular (IM) injection in pigs (Raekallio et al., 2008), and reduced nociceptive 84 
thresholds in piglets with kaolin-induced inflammation up to 24 hours after IM injection 85 
(Fosse et al., 2011). This study investigated the use of ketoprofen after farrowing for 86 
  
primiparous (hereafter referred to as gilts) and multiparous (referred to as sows) breeding 87 
pigs. The aim was to evaluate the benefits of post-farrowing ketoprofen in terms of: i) 88 
gilt/sow feed intake; ii) immune transfer using IgG from colostrum and piglet serum; iii) 89 
piglet performance including growth and mortality; and iv) nursing behaviour. Based on 90 
previous studies, our hypothesis was that prompt post-farrowing treatment with ketoprofen 91 
improves sow recovery, including feed intake, and piglet performance through immune 92 
transfer and nursing behaviour. 93 
Materials and Methods 94 
 This experiment was carried out under UK Home Office Licence, in compliance with 95 
EU Directive 2010/63/EU and following approval from the SRUC Animal Welfare and 96 
Ethical Review Body (AWERB). 97 
Animal housing and husbandry 98 
 Thirty-two Large White × Landrace multiparous (mean parity 4.63 ± 0.43) and 24 99 
primiparous sows were used in this study. The study was carried out at the SRUC pig 100 
research farm (Midlothian, UK), with gilts and sows farrowing in nine batches between 101 
February and October 2014. No more than five days before the expected farrowing date, gilts 102 
and sows were moved into individual farrowing crates (1.8 × 0.5 m), with solid concrete 103 
flooring (1.8 × 1.5 m), a small slatted area at the back (0.5 × 0.5 m) and a water and feed 104 
trough at the front. Piglets had access to a heated creep area (1.5 × 0.65 m) in front of the 105 
water and feed trough. Gilts and sows were fed a standard pelleted lactation diet twice daily 106 
at 0745 and 1530 and had continuous access to fresh water. Gilt and sow crates were cleaned 107 
daily at the morning feed, and they were provided with fresh, long-stemmed straw. 108 
Additional straw was added and manure removed at the afternoon feed in the days preceding 109 
  
farrowing. Lights were switched on immediately before the morning feed, turned off at 1630 110 
and an additional night-light was provided in the centre of each room of crates.  111 
During the experiment and only after the six hour post-injection data collection, cross-112 
fostering was conducted where necessary to even up litter sizes to maximise piglet survival as 113 
per normal farm practice. Cross fostering was conducted regardless of experimental 114 
treatments. When litter sizes were uneven, the largest piglet(s) were removed and placed on a 115 
gilt or sow with a smaller litter. Beyond the time of cross-fostering, data for individual foster 116 
piglets was then recorded against the foster sow. Piglets received an intramuscular injection 117 
of iron on day 3 post-farrowing, and on the fourth week after farrowing (mean age 26.39 ± 118 
0.20), weaning took place. At weaning, piglets were ear tagged and vaccinated (CircoFLEX) 119 
as per farm practice. 120 
Blinding and treatments 121 
This study was a randomised, blinded, placebo controlled trial, with gilts and sows 122 
allocated to receive a single intra-muscular (IM) injection of ketoprofen (Ketofen; Merial 123 
Animal Health Limited, Harlow, Essex, UK) or the equivalent volume of saline, 90 minutes 124 
following the birth of the last piglet.  Gilts and sows in each batch were randomly allocated to 125 
receive either ketoprofen (treated; 3 mg per kg bodyweight or 1 ml per 33 kg pre-farrowing 126 
bodyweight rounded down to the nearest 0.5 ml) or the equivalent volume of saline as a 127 
placebo control (control). The 56 individuals were balanced as much as possible across 128 
batches and for parity over the two treatment groups, however, an error in the treatment 129 
allocation, resulted in unbalanced groups for gilts (gilts: treated, n = 11, control, n = 13; 130 
sows: parity 2 to 4; treated, n = 9, control, n = 8; parity 5 to 7; treated, n = 5, control, n = 6; 131 
parity 8+; treated, n = 2, control, n = 2). One experimenter allocated individuals to the two 132 
treatment groups and a second added the ketoprofen or saline to individual brown medicine 133 
  
bottles, sealed with rubber stoppers (Adelphi Healthcare Packaging, Haywards Heath, West 134 
Sussex, UK), which were labelled only with the individual gilt or sow ear tag for 135 
identification. Ketofen contains the active ingredient ketoprofen at 100 mg/ml contained in a 136 
solution of l arginine, benzyl alcohol (10 mg/ml), citric acid monohydrate and water. It is a 137 
clear colourless solution, with low viscosity, making it indistinguishable from the saline 138 
placebo to the third experimenter administering the injection, who was unaware of the 139 
treatment.  140 
Individuals were closely monitored for signs of farrowing, by observation at twice 141 
daily feeding and through remote monitoring using a CCTV digital surveillance system 142 
around the clock. Once the piglet expulsion phase began, the time of each piglet birth was 143 
recorded; and 90 minutes after the last piglet birth and the gilt or sow appeared to have 144 
finished farrowing, ketoprofen or saline was administered by intra-muscular injection. 145 
Ketoprofen or saline were injected into the neck muscle, just behind the ear using an 18 146 
gauge, 1.5 inch needle attached to a PVC extension tube and using a 10 or 20 ml syringe 147 
(Henry Schein Animal Health, Dumfries, Dumfries and Galloway, UK). Following treatment 148 
administration, individuals were left undisturbed. 149 
Piglet measurements 150 
 Six hours after the treatment administration, the litters were processed and three 151 
piglets per litter were blood sampled. All piglets were collected and shut into the heated creep 152 
area during processing. Each piglet was weighed, crown-rump length measured (from the tail 153 
base to the top of the crown, in between the ears) and were labelled numerically on the back 154 
with a permanent marker. Three piglets per litter were selected to be blood sampled for 155 
immunoglobulin-G (IgG), based on weight: one less than 1.3 kg, one between 1.31 and 1.63 156 
kg and one greater than 1.64 kg, balanced across litters for sex. If piglets at all weight ranges 157 
  
were not available, alternatives were selected as close as possible, and very weak piglets were 158 
avoided.  159 
Selected piglets then had a topical local anaesthetic cream (EMLA) applied to their 160 
right ear. Each piglet was then held, while cotton wool soaked in hot water was applied to the 161 
right ear to promote vasodilation. A general purpose surgical steel lancet (HawksleyVet, 162 
Lancing, Sussex, UK) was used to make a small incision in the most prominent ear vein. 163 
Blood was allowed to pool briefly and collected into at least five 50 μl plain capillary tubes 164 
(HawksleyVet, Lancing, Sussex, UK). Blood was left to coagulate in the tubes for one hour at 165 
room temperature, before being sealed at one end using Cristaseal wax plates (HawksleyVet, 166 
Lancing, Sussex, UK), and then placed into a micro haemocrit centrifuge (HawksleyVet, 167 
Lancing, Sussex, UK)  for 1.5 minutes at 13,000 g. The end of the tube containing the 168 
condensed cells was cut off and the serum was pushed out of the remaining section of tube 169 
using a clean needle and syringe into a clean, pre-labelled 1.5 ml tube. Samples were then 170 
stored at -70 
o
C to be assayed at a later date.  171 
On day three post-farrowing, piglets were weighed when they were given a routine 172 
iron injection. At weaning, piglets were weighed and their crown-rump distance measured. 173 
All piglet deaths from birth to weaning were recorded and the cause of death identified by 174 
visual examination, and from video recording, including: still birth, crushing by the sow, low 175 
viability, starvation, savaged, ‘greasy pig’ (exudative epidermatis) and ‘other’ (unidentified 176 
causes). During the experiment, several litters were affected by exudative epidermatis, a 177 
bacterial skin infection, which was unrelated to the study, and was treated with long-acting 178 
antibiotics (amoxicillin). 179 
Gilt and sow measurements 180 
  
On moving in before farrowing and out at weaning, all gilts and sows were weighed, 181 
body condition scored (1 = very thin, 2 = thin, 3 = not too thin, not too fat, 4 = fat, 5 = very 182 
fat) and had their back-fat depth measured at the P2 position (Piglog 105; Carometec Food 183 
Technology, Smørum, Denmark).  184 
 At six hours after the treatment during piglet processing, a colostrum sample was 185 
collected from the dams. This was done by gently rubbing the udder, to ensure the dam was 186 
calm, then expressing colostrum from as many different teats as possible into a clean 30 ml 187 
plastic tube. Approximately 5 ml of colostrum was collected in the tube before pipetting into 188 
three 1.5 ml pre-labelled tubes, which were stored at -20
o
C to be assayed for IgG at a later 189 
date.  190 
 Gilt and sow feed intake was recorded on the day of farrowing, until seven days post-191 
farrowing. Individuals were fed a standard pelleted lactation diet consisting of 16.4% crude 192 
protein, 6.8 % crude oils and fats, 4.0% crude fibre, 5.8% crude ash, 13.8% moisture, 0.8% 193 
calcium, 0.94% lysine, 0.25% methionine, 0.51% phosphorus and 0.22% sodium. Gilts and 194 
sows were fed, based on a feed chart, which was adjusted slightly according to the size, body 195 
condition and appetite of the individual (e.g. gilts were fed slightly less than sows and a 196 
reduced body condition score was given slightly more feed). Feed intake was restricted, and 197 
increased gradually from day 0 to day 7. The amount fed was marked on the feed chart (in 198 
kg) and the amount left over from the previous feed was removed, weighed and recorded at 199 
the next feeding time. 200 
Behaviour 201 
Closed-circuit television (CCTV) cameras (LL20, infra-red cameras, FR concepts, 202 
Ireland) were mounted above each farrowing crate and were connected to a computer to 203 
record behaviour using GeoVision Digital Surveillance System software (ezCCTV ltd, Herts, 204 
  
UK). This surveillance system was also set up to enable remote monitoring of individuals. 205 
Digital video footage was collected and stored to be observed later using The Observer XT 206 
11.0 (Noldus Information Technology, Wageningen, The Netherlands). Three hour 207 
observations were made for suckling behaviour between 15 and 18 hours after the last piglet 208 
was born, to coincide with a regular pattern of milk let down and udder massage by the 209 
piglets, (Castren et al., 1989) which enabled obvious nursing bouts to be recognised on video. 210 
The frequencies and duration of suckle grunting (rapid flank movements indicating suckle 211 
grunting), whether more than 50% of piglets were active at the udder (performing udder 212 
massage/rapid suckling movements), as well as gilt and sow posture (stand, sit, kneel, lie 213 
lateral, lie ventral) and drinking behaviour (snout in the drinking trough with head 214 
movements indicating drinking behaviour) were recorded. 215 
Analysis of Immunoglobulin G (IgG) concentrations  216 
Sow colostrum and piglet serum samples were assayed for IgG using an enzyme 217 
linked immunosorbent assay (ELISA) kit (Bethyl Laboratories, Inc., Montgomery, Texas, 218 
USA). Colostrum and serum samples were removed from the freezer and allowed to thaw 219 
gradually at 4 
o
C overnight before the assay. On the day of the assay, samples were removed 220 
from the fridge, placed at room temperature for 30 minutes before further preparation.  221 
Colostrum samples were centrifuged twice at 16,249 g for 2 minutes, removing the fat 222 
layer after each spin. Serum samples were centrifuged for one minute at 865 g. Assays were 223 
then conducted according to the manufacturer’s instructions, with samples tested in duplicate. 224 
A test assay was run, indicating that a 1:500,000 dilution was best for both sample types. This 225 
dilution was created using serial dilution in, un-coated V-bottomed 96-well plates. 226 
Quality control (QCs) samples were created using pooled colostrum samples to run 227 
across and between plates to measure drift within and between plates. To avoid drift in the 228 
  
time taken to add the samples to the coated plate, 130 μl of standards, blanks, samples and 229 
QCs were added to an uncoated 96-well plate according to the plate layout, before using a 230 
multi-channel pipette to transfer into the coated plate. The plate was read using a 231 
Multiskan
TM
 FC Microplate Photometer plate reader and results calculated using a 5 point 232 
logistic regression curve using Thermo Scientific SkanIt
TM
 for Multiskan
TM
 FC software 233 
(version 2.5.1) (Thermo Fisher Scientific Inc, Waltham, Massachusetts, USA). Samples were 234 
spread across nine assay runs, balanced as much as possible for treatment, sample type 235 
(colostrum or serum), for gilts and sows and between farrowing batches. Duplicate samples 236 
with a coefficient of variation (CV) above 10% were repeated and those that failed to reach a 237 
CV% of less than 10% were left as missing values. The assay range was 1.37 – 1000 ng/ml.  238 
The lower and upper detectable limits of the samples analysed were 4.76 and 77.37 239 
ng/ml respectively. The average intra-assay CV was 6.66% (7.79, 6.91, 4.51, 6.69, 9.35, 6.17, 240 
6.58, 9.07 and 2.82 for assay runs 1 to 9 respectively) and the inter-assay CV was 8.69%.  241 
Data analysis 242 
Unless stated at the start of each results section, data were available for all 243 
individuals. Due to an error in the treatment allocation for gilts, there were 11 gilts and 16 244 
sows in the ketoprofen treated group and 13 gilts and 16 sows in the saline control group. An 245 
additional factor in this study was that 13 individuals; 5 gilts (4 treated and 1 control 246 
treatment) and 8 sows (4 treated and 4 control treatments) required additional treatment in the 247 
days after farrowing for PPDS. Therefore, data were analysed by treatment (treated vs. 248 
control), parity group at the level of gilt vs. sow and whether additional treatment was needed 249 
(yes vs. no). All data were analysed and descriptive statistics calculated using R version 3.3.1 250 
(R core team, 2013). All figures were plotted using the ggplot2 function, and any correlations 251 
  
were conducted using the spearman.test function. Results were considered statistically 252 
significant at P < 0.05. 253 
Feed intake 254 
 Feed consumed was analysed with linear mixed models, using the lmer function, with 255 
dam identity and batch in the random model. Initially, total feed consumed was analysed with 256 
treatment (treated or control), parity group (gilt or sow) and additional treatment (yes or no) 257 
and their interactions as fixed factors. Then each of the factor interactions with day was tested 258 
(0, 1, 2, 3, 4, 5, 6, and 7), including: day × treatment, day × gilt/sow and day × additional 259 
treatment. Post hoc analyses were conducted using the lsmeans function. 260 
Immunoglobulin-G (IgG) 261 
 Colostrum IgG concentrations (mg/ml) were analysed using linear mixed models with 262 
the lmer function, with batch in the random model. Treatment (treated or control), parity 263 
group (gilt or sow) and additional treatment (yes or no), and their interactions, and the 264 
number of piglets born alive were added as fixed factors. Piglet serum IgG was also analysed 265 
using the lmer function, with dam identity and batch in the random model, also with 266 
treatment (treated or control), parity group (gilt or sow) and additional treatment (yes or no) 267 
and their interactions, and piglets born alive as fixed factors. A Spearman’s rank correlation 268 
coefficient was calculated between piglet weight (kg) and IgG concentration (mg/ml), 269 
resulting in no significant correlation (rho = 0.039, P = 0.64), therefore piglet weight was not 270 
included in the model. 271 
Production data 272 
 The frequency of piglets born alive, still born, and number weaned, as well as live-273 
born pre-weaning deaths were analysed at the litter level with a generalized linear mixed 274 
  
model, using the glmer function, using a Poisson distribution and log link function. Sow 275 
weights, bat-fat thickness, and piglet weights and crown rump distances were analysed using 276 
linear mixed models with the lmer function. The number of piglets born alive was included as 277 
a random variable in the piglet mortality model. Gilt/sow identity and batch were included in 278 
the random model for the piglet measures, and batch for the sow measures. Treatment, 279 
additional treatment, gilt or sow and the interactions as fixed factors in all models. No piglets 280 
were fostered before the 6 hour post-injection sampling, therefore fostered piglets were 281 
analysed with their birth dam for the 6 hour post-injection measures, and with their foster 282 
dam for the other piglet measures. Sow weight and back-fat thickness was then analysed with 283 
moving in or post-weaning as a fixed factor, also with batch and ID in the random model. 284 
Body condition scores were analysed with ordinal logistic regression models using the polr 285 
function, with treatment, additional treatment, gilt or sow and the interactions, and batch as 286 
fixed factors, and with moving-in or post-weaning, and batch as fixed factors. 287 
Piglets that were born alive were allocated as dead (yes) or alive (no) by weaning. A 288 
stepwise binomial logistic regression was conducted using the glm and AIC.step functions, to 289 
analyse associations between variables, and whether piglets died before weaning (yes or no). 290 
Variables included: treatment (treated or control), additional treatment (yes or no), gilt or 291 
sow, batch, litter size at birth, piglet gender, piglet post 6 hour weight, and whether the piglet 292 
was fostered (yes or no), as well as sow back-fat, body condition score, farrowing duration 293 
(previously obtained from video footage), and lie lateral duration from behavioural 294 
observations. Variables were chosen, based on available data, and including known risk 295 
factors for piglet mortality (e.g. Baxter and Edwards, 2015).  296 
Behaviour 297 
  
Postures (stand, sit, kneel, lie lateral, lie ventral), suckle grunting and the duration 298 
when there were more than 50 % of piglets active at the udder, were converted to percentages 299 
of the three hour observation duration. The frequency of posture changes during the three 300 
hour observation period was also calculated. Individual bouts of suckle grunting were 301 
exported from The Observer for each gilt or sow, to calculate the frequency of bouts, the 302 
mean duration of each bout, and the mean inter-bout intervals. These behavioural variables 303 
were analysed using linear mixed models with the lmer function, including treatment (treated 304 
or control), parity group (gilt or sow) and additional treatment (yes or no) and their 305 
interactions as fixed factors, with batch in the random model. 306 
Results 307 
Feed intake 308 
 Total feed consumed did not differ by treatment × gilt/sow (t = -0.49, P = 0.62), 309 
treatment × additional treatment (t = 1.39, P = 0.17), or gilt/sow × additional treatment (t = 310 
1.19, P = 0.23), by treatment (t = 0.33, P = 0.74), or between gilts and sows (t = 1.37, P = 311 
0.17) (Fig.1). However, total feed consumed differed by day × additional treatment (t = -3.65, 312 
P = 0.0003), day × gilt/sow (t = 3.20, P = 0.002), and overall by additional treatment (t = -313 
2.92, P = 0.004). Post hoc analysis revealed that sows consumed more feed compared with 314 
gilts on days 6 and 7 post-farrowing (Fig.1 b) and that although individuals requiring 315 
additional treatment consumed less feed throughout, the difference was not significant until 316 
day 2 post farrowing (Fig.1 c). 317 
Immunoglobulin-G (IgG) 318 
Colostrum IgG concentrations were available for 52 of the 56 gilts and sows. No 319 
significant interactions (treatment × gilt/sow: t = 0.40, P = 0.69; treatment × additional 320 
  
treatment: t = 0.85, P = 0.40; gilt/sow × additional treatment: t = -0.32, P = 0.75) were found, 321 
or differences for treatment (t = -0.81, P = 0.42), between gilts and sows (t = 0.73, P = 0.47), 322 
or with additional treatment (t = -0.14, P = 0.89) (Fig.2, A-C). 323 
Of the 168 piglets that were blood sampled, serum IgG concentrations were available 324 
for 147 piglets. There were no differences by treatment × gilt/sow (t = -0.75, P = 0.46), 325 
treatment × additional treatment (t = 1.03, P = 0.31), or gilt/sow × additional treatment (t = -326 
0.78, P = 0.44). Piglets from sows had greater IgG concentrations than those from gilts (t = 327 
2.10, P = 0.04), but piglet serum IgG, did not differ by treatment (t = -0.15, P = 0.88), or 328 
additional treatment (t = -0.22, P = 0.82) (Fig.2, D-F).   329 
Production data 330 
Table 1 presents production information, including litter, gilt/sow- and piglet-based 331 
measures, by treatment, for gilts and sows, and by additional treatment. Table 2 presents the 332 
total frequencies and causes of death, and frequencies of piglets fostered on and off treated 333 
and control gilts and sows, to illustrate the total numbers of piglet deaths by treatment for 334 
gilts and sows, and the imbalance in piglet fostering between treatments. Figure 3 is a dot plot 335 
showing the number of live-born deaths for individual treated and control gilts and sows, 336 
which shows the individual variation in piglet pre-weaning deaths. There were no significant 337 
treatment × gilt/sow, treatment × additional treatment, or gilt/sow × additional treatment 338 
interactions for any of the results presented in Table 1 (P > 0.05). As shown, none of the 339 
results presented differed by treatment, or additional treatment (P > 0.05). However, pre-340 
farrow and post-wean weight differed between gilts and sows, as did the piglet weight and 341 
crown-rump measurements for piglets from gilts and sows (see Table 1). In addition, gilt or 342 
sow weight (t = -12.25, P < 0.001), back-fat (t = -10.66, P < 0.001), and body-condition (t = -343 
5.12, P < 0.001) were greater overall pre-farrowing, compared with post-weaning.  344 
  
Of the 705 piglets born alive, any row with missing values for any of the variables 345 
was excluded, leaving 659 rows of data for analysis. The best logistic regression model 346 
included the variables piglets born alive, additional treatment, piglet gender, sow back-fat, 347 
and piglet 6 hour post-injection weight, which were significant predictors of death before 348 
weaning. For every increase in piglet born alive in the litter, the log odds of dying before 349 
weaning increased (log-odds = 0.11, P = 0.03). Requiring additional treatment (log-odds = 350 
0.87, P = 0.006), as well as being male (log-odds = 0.97, P = 0.0005) increased the log odds 351 
of dying before weaning. For every mm increase in gilt or sow back-fat, the log-odds of 352 
piglet death increased (log-odds = 0.16, P < 0.0001). Every kg increase in piglet 6 hour post-353 
injection bodyweight, decreased the log-odds of dying before weaning, (log-odds = -4.18, P < 354 
0.0001). 355 
Behaviour 356 
Behaviour was observed for 53 of the 56 individuals and results are shown in Table 2. 357 
There were no significant interactions for treatment × gilt/sow, treatment × additional 358 
treatment, or gilt/sow × additional treatment, for any of the behaviours shown in Table 3 (P > 359 
0.05).  For nursing behaviour, ketoprofen treated dams suckle grunted less (t = -2.02, P = 360 
0.05) than the controls, but there were no other differences between treatment groups, gilts 361 
and sows and those requiring additional treatment or not (P > 0.05). For the postures 362 
observed, sitting and kneeling behaviour differed between gilts and sows (t = 2.08, P = 0.04 363 
and t = 2.49, P = 0.02 respectively), with greater values for sows compared with gilts. Lying 364 
lateral also differed (t = -2.38, P = 0.02) with greater values for gilts than sows. There were 365 
no differences in drinking behaviour between treatment groups, gilts and sows or those 366 
requiring additional treatment or not (P > 0.05). 367 
Discussion  368 
  
This study investigated effects of the provision of the NSAID ketoprofen to gilts and 369 
sows following farrowing. Few effects of the treatment were seen, with production 370 
parameters being more affected by whether individuals were treated for disease, or between 371 
gilts and sows.  372 
Feed intake 373 
 In contrast to a previous study (Viitasaari et al., 2013), there was no difference in feed 374 
consumption by gilts or sows given ketoprofen compared with controls. The previous study 375 
administered ketoprofen for three consecutive days following farrowing, which could have 376 
had a greater effect on sows, and overall feed refusal rather than consumption was measured 377 
(Viitasaari et al., 2013). In another study where the NSAID meloxicam was administered for 378 
three days post-farrowing, feed intake was not affected by drug treatment, but a difference 379 
between primiparous and multiparous sows was found, as multiparous sows had consumed a 380 
greater number of meals within an hour of feeding on days one, two and three post-farrowing 381 
(Mainau et al., 2012). In the current study, sows consumed more feed than gilts on days six 382 
and seven post-farrowing, as sows increased their feed intake at a greater rate than gilts. The 383 
feed that was not consumed was only measured at the next feeding time in this study, 384 
whereas the previous study scored feed as being completely consumed or not, one hour after 385 
it was given (Mainau et al., 2012). From day two after farrowing, and overall, there was a 386 
difference in the amount of feed consumed by individuals that required additional treatment 387 
compared to those that did not. This is not surprising as reduced feed intake is a good 388 
indicator of illness. In future studies, it would be interesting to measure the latency to feed 389 
and the time taken to fully consume the meal, as this could be an early indicator of subclinical 390 
PPDS and prompt treatment could produce a better outcome for the sow and litter. 391 
  
Immune transfer 392 
 Piglets obtain passive immunity through the ingestion of immunoglobulin from sow 393 
colostrum (Rooke and Bland, 2002), and those with low concentrations of immunoglobulin 394 
are less likely to survive (Cabrera et al., 2012). Therefore, this is an important measure in 395 
identifying the benefits of administering post-farrowing NSAIDs. No differences in 396 
colostrum or piglet serum IgG concentrations were detected in this study with drug treatment 397 
or whether additional treatment was required. A previous study found greater colostrum 398 
concentrations of piglets on day one and two post-farrowing from sows given oral meloxicam 399 
at farrowing (Mainau et al., 2016). As piglets were numerically heavier at six hours post-400 
injection in this study, which could indicate greater colostrum intake, a difference may have 401 
been found if piglets were sampled at later time points. 402 
Some studies have shown a link between colostrum intake and piglet birth weight 403 
(Devillers et al., 2007; Fraser and Rushen, 1992; Nguyen et al., 2013; Quesnel, 2011), 404 
although the link between colostrum consumed and piglet plasma IgG concentration plateau 405 
over a certain value, i.e. the link is stronger at lower concentrations (Devillers et al., 2011). 406 
No association between piglet weight and IgG at the point of sampling was found in this 407 
study, which was similar to a previous study (Cabrera et al., 2012), however, this could be 408 
explained by excessively small and/or weak piglets not being selected for blood sampling in 409 
the current and previous study (Cabrera et al., 2012). In addition, Fraser and Rushen, (1992) 410 
suggest that the failure to find a link between birth weight and IgG could be because of 411 
differences in blood volume (affecting the concentration) between large and small piglets.  412 
Sow colostrum had a numerically greater IgG concentration than gilt colostrum, and 413 
piglet serum IgG was greater for piglets from sows compared with gilts. No link between 414 
piglet plasma IgG concentration and parity was detected at birth in one study (Quesnel, 415 
  
2011), and another study showed a similar result, although it was not mentioned whether 416 
primiparous sows were included (Nguyen et al., 2013). Other studies measuring sow 417 
colostrum have found differences by parity, including lower concentrations measured 24 418 
hours after birth in lower parity sows (Quesnel, 2011) and lower colostrum IgG 419 
concentrations in primiparous compared with multiparous sows 48-72 hours after birth 420 
(Cabrera et al., 2012). 421 
Production data  422 
 There were no overall significant differences in pre-weaning piglet deaths, weight or 423 
size by treatment, or between those requiring additional treatment or not. However, it is 424 
worth discussing that numerically fewer piglets died in the ketoprofen compared with the 425 
saline-treated group, especially for gilts. High individual variation in piglet mortality was 426 
seen in this study, which possibly resulted in this difference not reaching significance. As 427 
piglet weight six hours after the injection was also numerically greater in ketoprofen-treated 428 
gilts and sows, it is also possible that piglet birth weight was greater for treated gilts and 429 
sows, resulting in the mortality difference. It is also possible that ketoprofen treatment 430 
increased piglet weight at six hours through increased colostrum intake, however, based on 431 
previous studies measuring early piglet weight gain, this may not have accounted for all of 432 
this weight difference (e.g. de Passillé and Rushen, 1989; Fraser and Rushen, 1992; Quesnel, 433 
2011). This cannot be confirmed, since piglets were not weighed before the injection was 434 
given, and in a previous study, where 16 sows were randomly allocated to be given 435 
butorphanol tartrate or a saline placebo post-farrowing, Haussmann et al., (1999) found a 436 
significant difference in birth weight of the piglets, with those from control sows being 437 
significantly heavier. So this may be an accidental outcome in this study and an important 438 
consideration for the piglet mortality difference between treatment groups.  439 
  
A reduction in piglet mortality with the use of ketoprofen post-farrowing has been 440 
demonstrated previously in a study of 15 commercial farms (Homedes et al., 2014) and on a 441 
farm with a high incidence of PPDS (Sabaté et al., 2012), but another study reported no 442 
difference in mortality with the use of ketoprofen (Viitasaari et al., 2013). The individuals 443 
responsible for the care of the animals in the current study were blind to the treatments, and 444 
cross-fostering was performed to even litter size, resulting in more piglets being fostered off 445 
the ketoprofen-treated gilts and more piglets being fostered onto the control gilts. This meant, 446 
despite a difference in mortality, no difference in the numbers of piglets weaned was detected 447 
between treatment groups for gilts, which is a result found in previously, where fostering was 448 
only conducted within treatment groups (Homedes et al., 2014; Sabaté et al., 2012). If 449 
ketoprofen does have an influence on piglet mortality, given the individual variation in the 450 
number of deaths, early identification to enable targeted use of drugs to those that could 451 
benefit the most would be the best use of drugs. No difference in mortality between treatment 452 
groups was detected the post-farrowing administration of the NSAID meloxicam (Mainau et 453 
al., 2012; Tenbergen et al., 2014) or with the opioid butorphanol tartrate (Haussmann et al., 454 
1999). However, average daily weight gain of low birth weight piglets (<1180g) was 455 
increased (Mainau et al., 2012), growth rate of medium sized litters (11 to 13 piglets) tended 456 
to be greater (Tenbergen et al., 2014), and average daily gain and weaning weight was greater 457 
(Mainau et al., 2016) for multiparous sows treated with meloxicam compared with a placebo.  458 
Piglet mortality in this study was most influenced by previously demonstrated risk 459 
factors, including piglet weight, sow back-fat, piglet gender, sow post-farrowing illness and 460 
the number of piglets born alive (for a review see Baxter and Edwards, 2015). It is widely 461 
agreed that birth weight is the most important factor in neonatal piglet survival and lower 462 
average piglet weight at six hours post-injection in this study was most strongly associated 463 
with pre-weaning death. Larger litter sizes come at the expense of reduced piglet viability, as 464 
  
well as increased competition for colostrum and milk (Baxter and Edwards, 2015). 465 
Interestingly, greater sow back-fat was associated with an increase in the odds of a piglet 466 
dying before weaning. A previous study using a high number of sows found a quadratic effect 467 
of sow back-fat at farrowing on the number of piglets weaned, with low and high back-fat 468 
being associated with fewer piglets weaned (Kim et al., 2015). Male-biased pre-weaning 469 
mortality has been found elsewhere, where piglets born were male-biased, and males were 470 
heavier at birth (Baxter et al., 2012). This demonstrates a life-history strategy in domestic pig 471 
populations, with greater pre-natal maternal investment and an over-supply of more 472 
vulnerable males, in expectation of greater mortality (Baxter et al., 2012). Litter from sows 473 
developing PPDS suffer greater mortality (Klopfenstein et al., 2006), and treatment with 474 
NSAIDs in addition to antibiotics, can aid in the treatment of infectious causes of PPDS 475 
(Sabaté et al., 2012; Tummaruk and Sang-Gassanee, 2013).   476 
Behaviour 477 
Posture was observed during nursing behaviour observations, with no differences by 478 
treatment. Previous studies investigating the administration of ketoprofen (Viitasaari et al., 479 
2014) and meloxicam (Mainau et al., 2012) for three consecutive days post-farrowing showed 480 
differences in the level of activity between individuals given the NSAID or a saline placebo 481 
only on the third day post farrowing. This included a decrease in the time spent lying by 482 
meloxicam treated gilts and sows (Mainau et al., 2012) and an increased activity in younger 483 
(parity 2 -3) sows treated with ketoprofen, compared with their placebo treated counterparts, 484 
although older sows did not differ (Viitasaari et al., 2014). Greater activity suggests an 485 
improvement in the speed of recovery following parturition with the use of NSAIDs. By 486 
contrast, another study, using the opioid analgesic butorphanol tartrate post-farrowing 487 
  
showed a reduced number of posture changes 48 hours post farrowing (Haussmann et al., 488 
1999).  489 
Sows showed more sitting and kneeling behaviour compared with gilts, which could 490 
be related to the difference in size, weight and fitness between these two groups and the ease 491 
of changing body position. The gilts in this study spent more time lying lateral, in contrast to 492 
a previous study that showed younger sows to be more active (Viitasaari et al., 2014). This 493 
could be due to genetic improvements, as the gilts in this study were acquired directly from a 494 
breeding company, whereas the sows were home bred from an older genetic line of the same 495 
breed. Modern breeding programs have focused on maternal traits to improve productivity, 496 
which could be reflected in greater lateral lying, allowing piglets access to the udder. 497 
Although there were no significant differences in posture between individuals that required 498 
additional treatment for PPDS, numerical differences for postures and the frequency of 499 
posture changes indicate PPDS individuals appear less active and, as with a reduction in feed 500 
intake, could be used as an early indication of PPDS to provide prompt treatment.      501 
For the nursing behaviours observed, there was greater suckle grunting in control, 502 
compared with ketoprofen-treated dams. This data could indicate that ketoprofen dams had 503 
settled into a pattern of milk let-down sooner, providing support for the fact that the weight 504 
difference between ketoprofen and control-treatment dams could be due to greater colostrum 505 
intake. No previous studies have recorded nursing behaviour in relation to the use of post-506 
farrowing NSAIDs. 507 
Conclusion 508 
This study did not demonstrate production benefits to the immediate post-farrowing 509 
administration of ketoprofen. However, in this study, as with others, high individual sow 510 
variation in piglet mortality was seen, with some performing well and the majority of piglet 511 
  
mortality often coming from a low number of sows (Baxter et al., 2015; Hales et al., 2013). 512 
Investigating whether pain is a component of decreased performance in these sows, could 513 
enable the targeted use of drugs. Additionally, identifying sows that could benefit from pain 514 
relief using measures of farrowing ease (e.g. Mainau et al., 2010), feed intake, activity and 515 
other behaviour measures, could assist with targeted drug treatment. 516 
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Fig.1. Mean ± SEM of the total feed consumed (kg) per day by a) treatment (treated or 620 
control); b) gilts and sows and; c) additional treatment (yes or no). Bars with a * indicate a 621 
significant difference (P < 0.05). 622 
Fig.2. Mean ± SEM for colostrum immunoglobulin-G concentrations (mg/ml) for A) gilts and 623 
sows × treatment; B) additional treatment (yes or no) × drug treatment and; C) additional 624 
treatment (yes or no) × gilts and sows. Mean ± SEM for piglet serum immunoglobulin-G 625 
concentrations (mg/ml) for D) gilts and sows × treatment; E) additional treatment (yes or no) 626 
× drug treatment and; F) additional treatment (yes or no) × gilts and sows. Labels on the bars 627 
indicate the number of samples represented. 628 
Fig.3. Dot plot of individual gilt or sow live-born piglet deaths by treatment. 629 
